Rheumatoid arthritis (RA) is a common autoimmune disease where the body's immune system mistakenly attacks the lining of its own joints, causing chronic pain, swelling, and stiffness. While there have ...

C-T-P, compound-target-pathway; DL, drug-likeness; GO, gene ontology; OB, oral bioavailability; PPI, protein-protein interaction; RA, rheumatoid arthritis; TCMSP ...

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the United States, announced the publication of new research in PLOS Pathogens identifying a novel mechanism that may trigger ...

Advances in RA treatment require improved understanding of patient-specific therapy appropriateness, focusing on disease pathogenesis and heterogeneity. Current RA treatment algorithms lack biomarkers ...

Idera Pharmaceuticals, Inc. IDRA announced today the presentation of IMO-3100 mechanism of action data in a preclinical model of arthritis. In this study, the improvements in disease-related ...

Data from several dozen human volunteers showed that blocking sEH raised epoxy-oxylipin levels and reduced harmful immune cell activity.